Publications by authors named "J Haapala"
Objective: Total hip arthroplasty through the Hardinge approach damages the hip abductor muscles. MRI can be used to assess adverse postoperative events. In this prospective randomized controlled trial, we evaluated MRI findings and whether platelet-rich plasma affected postoperative healing of the gluteal muscles (gluteus medius and minimus).
View Article and Find Full Text PDFImportance: Medication adherence is important for managing blood pressure (BP), low-density lipoprotein cholesterol (LDL-C), and hemoglobin A1c (HbA1c). Interventions to improve medication adherence are needed.
Objective: To examine the effectiveness of an intervention using algorithmic identification of low medication adherence, clinical decision support to physicians, and pharmacist outreach to patients to improve cardiometabolic medication adherence and BP, LDL-C, and HbA1c control.
Article Synopsis
- Early life gut microbiomes significantly impact brain and immune system development, with probiotics suggested as a way to enhance health through microbiome modification.
- This study investigates the effects of maternal probiotic exposure during pregnancy and breastfeeding on inflammation in breastmilk, variations in maternal and infant microbiomes, and infant neurodevelopment.
- Results indicate that maternal probiotics are linked to lower breastmilk inflammation markers and changes in infant gut microbiome, as well as improved recognition memory responses in infants at 6 months old.
Background: Previous studies have found that exposure to childhood environmental stress is associated with cardiometabolic risk. However, it is not known whether individual health behaviors disrupt this relationship. This study prospectively evaluated the relationship between cumulative environmental stress in a low-income sample and cardiometabolic risk in middle childhood and examined whether child health behaviors attenuated this relationship.
View Article and Find Full Text PDFArticle Synopsis
- The elimination of the X-waiver in January 2023 could boost the number of potential buprenorphine prescribers significantly (up to 13 times), but actual prescribing growth may not match this potential.
- A study surveyed 305 nonwaivered primary care clinicians to identify factors that would influence their likelihood of prescribing buprenorphine if the X-waiver was removed, focusing on patient requests and access to a clinical decision-support (CDS) tool for opioid use disorder (OUD).
- Results indicated that while only 26% of clinicians were influenced by patient requests to prescribe buprenorphine, 63% were more likely to do so with the help of the OUD-CDS, highlighting the need